DSM502   Click here for help

GtoPdb Ligand ID: 11219

Antimalarial Ligand
Compound class: Synthetic organic
Comment: DSM502 is the optimized lead from a pyrrole-based series of antimalarial compounds that inhibit P. falciparum dihydroorotate dehydrogenase (PfDHODH) [1]. This series of PfDHODH inhibitors could provide a potential backup candidate, with an alternative scaffold, to the clinical lead DSM265.

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 57.78
Molecular weight 323.12
XLogP 2.43
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1[nH]cc(c1C)Cc1ccc(nc1)C(F)(F)F)NC1CC1
Isomeric SMILES O=C(c1[nH]cc(c1C)Cc1ccc(nc1)C(F)(F)F)NC1CC1
InChI InChI=1S/C16H16F3N3O/c1-9-11(8-21-14(9)15(23)22-12-3-4-12)6-10-2-5-13(20-7-10)16(17,18)19/h2,5,7-8,12,21H,3-4,6H2,1H3,(H,22,23)
InChI Key AFOVOYRODSYDMK-UHFFFAOYSA-N
Guide to Malaria Pharmacology Comments
Although DSM502 demonstrates improved species selectivity, equivalent P. falciparum and P. vivax activity and a different resistance profile to DSM265, it is not as metabolically stable and would not be suitable as a single dose treatment or once-weekly chemopreventative [1]. The pyrrole-based series may however provide a candidate that could advance to preclinical development.

Potential Target/Mechanism Of Action: DSM502 is a selective inhibitor of malarial dihydroorotate dehydrogenase (DHODH) in vitro [1].